About Us

Founded in 2000, CNS has grown to become one of the largest clinical research providers in the country, and the largest in Southern California. CNS operates three outpatient clinics located in Southern California (Garden Grove, Long Beach and Torrance). Additionally, CNS’s Long Beach facility offers a dedicated Phase I Unit.

Learn More

About our studies

CNS, in partnerships with major pharmaceutical sponsors, conducts clinical trials for new medications and treatments in various therapeutic areas including neurology, psychiatry and general health conditions. The mission of CNS is to advance medical knowledge through seamless execution of complex clinical trials utilizing our extensive experience, knowledge and capabilities.

Open Studies

Participate in the Search for a Cure Today.

CNS is one of the foremost experts in psychiatric and neurological health with a diverse group of studies open for enrollment. With the help of participants like you, we are able to advance medical knowledge and get new treatments and medications available to the public! Additional benefits for volunteers include compensation for time, medical procedures and tests at no cost, and more. To see if you qualify contact CNS today.

About Clinical Trials

CNS, in partnerships with major pharmaceutical sponsors, conducts clinical trials for new medications and treatments in various therapeutic areas including neurology, psychiatry and general health conditions.

studies

Open Studies

facilities

FAQs

news

News & Events

Sign up to participate in a clinical trial today!

Contact Us Now

Therapeutic Areas

CNS News | Stay Up To Date

About Apex
Innovative Sciences

A leading provider of clinical development and trial site services, Apex was formed through the 2019 merger of CNS and Hassman Research Institute (HRI), a trial site organization based in New Jersey. The merger was the culmination of years of successful collaboration. Historically, CNS and HRI worked closely with each other to conduct high-quality research while sharing a Chief Scientific Officer and a business development team.

Study Participants
Ready to Take the Next Step?

Contact Us Now